Enfusion Results Presentation Deck
*:enfusion
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Non-cash operating lease expense
Depreciation and amortization
Provision for credit losses
Amortization of debt-related costs
Stock-based compensation expense
Change in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other assets
Accounts payable
Accrued expenses and other liabilities
ENFUSION. INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(dollars in thousands) (Unaudited)
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Purchases of property and equipment
Net cash used in investing activities
Cash flows from financing activities:
Settlement of tax receivable acquired in reorganization transaction
Payment of withholding taxes on stock-based compensation
Other
Net cash used in financing activities
Effect of exchange rate changes on cash
Net decrease in cash
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
$
$
Three Months Ended March 31,
2023
4,694
(40)
1,868
475
6
(1,147)
878
(1,153)
(395)
(4,262)
924
(2,550)
(2,550)
1,501
(7,579)
(275)
(6,353)
32
(7,947)
62,545
54,598
$
$
2022
(12,524)
1,340
123
6
12,682
(5,310)
(13)
(1,339)
938
(4,097)
(3,171)
(3,171)
(805)
(805)
(86)
(8,159)
64,365
56,206
Ⓒ2023 ENFUSION. ALL RIGHTS RESERVED.
16View entire presentation